91 related articles for article (PubMed ID: 1814626)
1. Fibrinolytic effect of tissue plasminogen activator on cerebral embolism in stroke-prone spontaneously hypertensive rats.
Kimata H; Nakajima K; Suzuki H; Koide T; Yamamoto S; Narita T
Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3327-30. PubMed ID: 1814626
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.
Kimata H; Nakajima K; Suzuki H; Koide T; Narita T
J Pharmacobiodyn; 1991 Jul; 14(7):399-406. PubMed ID: 1802987
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
[TBL] [Abstract][Full Text] [Related]
5. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
Absher PM; Hendley E; Jaworski DM; Taatjes DJ; Sobel BE
Coron Artery Dis; 1999 Sep; 10(6):413-20. PubMed ID: 10474793
[TBL] [Abstract][Full Text] [Related]
6. Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).
Hara T; Iwamoto M; Ogawa H; Yamamoto A; Tomikawa M
Thromb Res; 1990 Aug; 59(4):703-12. PubMed ID: 2127865
[TBL] [Abstract][Full Text] [Related]
7. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
[TBL] [Abstract][Full Text] [Related]
8. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
[TBL] [Abstract][Full Text] [Related]
9. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
10. Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat.
McGill JK; Gallagher L; Carswell HV; Irving EA; Dominiczak AF; Macrae IM
Stroke; 2005 Jan; 36(1):135-41. PubMed ID: 15569870
[TBL] [Abstract][Full Text] [Related]
11. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
12. Femoral head necrosis and osteopenia in stroke-prone spontaneously hypertensive rats (SHRSPs).
Naito S; Ito M; Sekine I; Ito M; Hirano T; Iwasaki K; Niwa M
Bone; 1993; 14(5):745-53. PubMed ID: 8268049
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
Penar PL; Greer CA
Yale J Biol Med; 1987; 60(3):233-43. PubMed ID: 3111108
[TBL] [Abstract][Full Text] [Related]
15. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
Kawakami K; Takahashi A; Yoshimoto T
No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
[TBL] [Abstract][Full Text] [Related]
16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
[TBL] [Abstract][Full Text] [Related]
18. Mild ischemia produces hippocampal neuronal death in stroke-prone spontaneously hypertensive rats.
Kinugawa H; Sakurai-Yamashita Y; Niwa M
Brain Res; 2008 Sep; 1229():204-9. PubMed ID: 18652809
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report.
Jafar JJ; Tan WS; Crowell RM
J Neurosurg; 1991 May; 74(5):808-12. PubMed ID: 1901602
[TBL] [Abstract][Full Text] [Related]
20. Cerebral plasminogen activator activity in spontaneously hypertensive stroke-prone rats.
Matsuo O; Okada K; Fukao H; Suzuki A; Ueshima S
Stroke; 1992 Jul; 23(7):995-9. PubMed ID: 1615551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
